Skip to main content
. 2023 Oct 9;15(10):e46738. doi: 10.7759/cureus.46738

Table 2. Observational studies on cranberry supplementation for UTI prophylaxis during pregnancy.

MBRN: Medical Birth Registry of Norway; WG: weeks of gestation; VB: vaginal bleeding; BW: birth weight; LBW: low birth weight; SGA: small for gestational age; ICD: International Classification of Diseases; w/o: without; SCM: sternocleidomastoid muscle

*MoBa is the Norwegian mother and child population-based prospective cohort study

Study Design/sample size Entry criteria Exposure/regimen Data collection Selected outcomes Results
Heitmann et al. (2013) [52] Nested prospective cohort study Inclusion criteria Cranberry use 1st questionnaire at 13-17WG PLUS routine fetal US at 17-18WG VB <17WG & ≥17WG 919 exposed subjects
Sample size: 68.522 1. MoBa study's participants (available MBRN records plus 1st questionnaire results) 1. Overall 2nd questionnaire at 30WG  Hospitalization due to VB <17WG & ≥17WG 566 exposed subjects <17WG (≥80% of statistical power to rule out all malformations, serious malformations, LBW, low Apgar score, preterm birth, neonatal infections, cardiac malformations, or stillbirth/neonatal death)
Exclusion criteria 2. Early pregnancy (<17WG) 3rd questionnaire at six months postpartum VB more than spotting after 17WG 122 exposed women during the first trimester revealed no increased risk of defects
1. Multiple pregnancies 3. Late pregnancy (≥17WG) All malformations 11 infants had malformations w/o specific pattern
2. Delivered infants had multiple birth defects Unknown daily dose, duration of treatment, total dose, and adjunct herbals  Stillbirth (≥22WG or BW of ≥425 gram) 1) two cases of hypospadias
LBW (<2500 grams) 2) two cases of macrocephaly
SGA (<10th percentile) 3) four cases of hip or feet dislocation/deformity
Preterm birth (<37WG) 4) one case of SCM deformity
Apgar score <7 at 5 minutes  5) one case of ankyloglossia
Neonatal infections (ICD-10 P35-39) 6) one case of undescended testicles
  Cranberry users more frequently experienced vaginal spotting after 17WG, but no association was found after adjustments for confounders